ArticleNature communications2023

CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy.

Xue Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.